Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Improving nasal-sounding speech and swallowing in head and neck cancer survivors with velopharyngeal dysfunction

Official title: Injectable Augmentation Outcomes in Post-Radiation Head and Neck Cancer Patients With Velopharyngeal Dysfunction

Run by University of Virginia · NCT07264036 · Data updated 2026-11-12

This pilot effort tests whether injecting material to 'plump' the back wall of the throat (pharyngeal wall augmentation) can help head and neck cancer survivors with velopharyngeal dysfunction speak less nasally and swallow better.

More Head and Neck Cancer trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorUniversity of Virginia
Academic / other
Drugs / interventionsradiation
Locations1 site (Charlottesville, Virginia)
StatusRecruiting
StartedMarch 24, 2026
Main results expectedJanuary 1, 2027
Study endsJuly 1, 2027
Registry record updatedApril 28, 2026
Trial IDNCT07264036 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

English-speaking adults (age 18+) who are head and neck cancer survivors with perceptual hypernasality and no suspected non-cancer causes of velopharyngeal dysfunction and who have no contraindication to augmentation are ideal candidates.

Probably not a fit

Patients with non–cancer-related VPD, those requiring more intensive active cancer surveillance, or those with planned future pharyngeal surgeries or anatomical problems not addressed by augmentation are unlikely to benefit from this intervention in the study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-site pilot that uses multidisciplinary, multimodal assessments to characterize velopharyngeal dysfunction (VPD) in head and neck cancer survivors. Participants undergo physical exam, flexible nasolaryngoscopy, speech recordings and acoustic analysis, nasometry, clinical swallowing evaluation, and fiberoptic endoscopic evaluation of swallowing (FEES). A subset with confirmed VPD will receive pharyngeal wall augmentation as part of routine clinical care, with pre- and post-intervention comparisons of speech, swallowing, and patient-reported outcomes. The study also aims to determine prevalence and to test the diagnostic usefulness of advanced measures like nasometry in this population.

Why it matters

Potential benefit: If successful, pharyngeal wall augmentation could reduce hypernasal speech, lower nasal regurgitation during swallowing, and improve speech- and swallowing-related quality of life for affected survivors.

How similar studies have gone: Augmentation approaches have shown benefit in small series and in non-cancer VPD populations, but data specifically in head and neck cancer survivors are limited, making this application relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

English-speaking adults (≥18 years) History of head and neck cancer treated with surgical resection, chemoradiation, or both Presence of perceptual hypernasality on clinical assessment

Exclusion Criteria:

Pre-existing or suspected non-cancer-related causes of velopharyngeal dysfunction Contraindications to pharyngeal wall augmentation Requirement for more intensive active cancer surveillance Planned future surgical or medical treatments to the pharynx that would interfere with participation

Where it's running

  • University of Virginia
    Charlottesville, Virginia, United States
    Recruiting

Study contacts

  • Principal investigator: Vanessa Torrecillas, MD — University of Virginia
  • Study coordinator: Vanesssa Torrecillas, MD
  • Email: vge3bm@uvahealth.org
  • Phone: 434-924-2040

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.